These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 17474312)
1. Treatment of HIV/HBV coinfection: clinical and virologic issues. Thio CL; Locarnini S AIDS Rev; 2007; 9(1):40-53. PubMed ID: 17474312 [TBL] [Abstract][Full Text] [Related]
2. Antiretroviral therapy and HIV/hepatitis B virus coinfection. Benhamou Y Clin Infect Dis; 2004 Mar; 38 Suppl 2():S98-103. PubMed ID: 14986281 [TBL] [Abstract][Full Text] [Related]
3. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients. Kumar R; Singla V; Kacharya Sk Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605 [TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls. Levy V; Grant RM Clin Infect Dis; 2006 Oct; 43(7):904-10. PubMed ID: 16941375 [TBL] [Abstract][Full Text] [Related]
6. [Hepatitis B in patients with HIV infection]. Barreiro P; Martín-Carbonero L; García-Samaniego J Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():71-9. PubMed ID: 19100234 [TBL] [Abstract][Full Text] [Related]
7. Detection of hepatitis B virus variants in HBV monoinfected and HBV/HIV coinfected Iranian patients under lamivudine treatment. Aghasadeghi MR; Bahramali G; Sadat SM; Farahani A; Mohraz M; Davar Siadat S; Mostafavi E; Memarnejadian A; Ardestani MS; Vahabpour R; Saraji AA; Delbaz SA Curr HIV Res; 2011 Jun; 9(4):263-9. PubMed ID: 21671883 [TBL] [Abstract][Full Text] [Related]
8. The impact of human immunodeficiency virus on viral hepatitis. Mallet V; Vallet-Pichard A; Pol S Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151 [TBL] [Abstract][Full Text] [Related]
9. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy. Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858 [TBL] [Abstract][Full Text] [Related]
10. Current treatment of HIV/hepatitis B virus coinfection. Iser DM; Sasadeusz JJ J Gastroenterol Hepatol; 2008 May; 23(5):699-706. PubMed ID: 18410604 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy. Gaglio PJ; Sterling R; Daniels E; Tedaldi E; Clin Infect Dis; 2007 Sep; 45(5):618-23. PubMed ID: 17682998 [TBL] [Abstract][Full Text] [Related]
12. Temporary HBV resolution in an HIV-coinfected patient during HBV-directed combination therapy followed by relapse of HBV. Wursthorn K; Buggisch P; Lutgehetmann M; Zollner B; Petersen J Antivir Ther; 2006; 11(5):647-52. PubMed ID: 16964835 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B in HIV-infected patients. Soriano V; Poveda E; Vispo E; Barreiro P Clin Liver Dis; 2013 Aug; 17(3):489-501. PubMed ID: 23905818 [TBL] [Abstract][Full Text] [Related]
14. Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV-HBV-coinfected patients with delayed response to tenofovir. Lada O; Gervais A; Branger M; Peytavin G; Roquebert B; Collin G; Fraqueiro G; Moucari R; Leclerc L; Martinot-Peignoux M; Matheron S; Marcellin P Antivir Ther; 2012; 17(1):61-70. PubMed ID: 22267470 [TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B with advanced fibrosis or cirrhosis: impact of antiviral therapy. Arora G; Keeffe EB Rev Gastroenterol Disord; 2007; 7(2):63-73. PubMed ID: 17597674 [TBL] [Abstract][Full Text] [Related]
16. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response. Jain MK; Comanor L; White C; Kipnis P; Elkin C; Leung K; Ocampo A; Attar N; Keiser P; Lee WM J Viral Hepat; 2007 Mar; 14(3):176-82. PubMed ID: 17305883 [TBL] [Abstract][Full Text] [Related]
17. Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study. Pellicelli AM; Barbaro G; Francavilla R; Romano M; Barbarini G; Mazzoni E; Mecenate F; Paffetti A; Barlattani A; Struglia C; Villani R; Nauri L; Nosotti L; Armignacco O; Ferri F; Camporiondo MP; Soccorsi F; Clin Ther; 2008 Feb; 30(2):317-23. PubMed ID: 18343270 [TBL] [Abstract][Full Text] [Related]
18. Baseline CD4+ T-cell counts predict HBV viral kinetics to adefovir treatment in lamivudine-resistant HBV-infected patients with or without HIV infection. Cortez KJ; Proschan MA; Barrett L; Brust DG; Weatherley B; Formentini E; Davey RT; Masur H; Polis MA; Neumann And AU; Kottilil S HIV Clin Trials; 2013; 14(4):149-59. PubMed ID: 23924587 [TBL] [Abstract][Full Text] [Related]
19. HIV and hepatitis B virus: options for managing coinfection. Dieterich DT Top HIV Med; 2003; 11(1):16-9. PubMed ID: 12717046 [TBL] [Abstract][Full Text] [Related]
20. Adefovir dipivoxil therapy in liver transplant recipients with lamivudine-resistant hepatitis B virus. Herreros de Tejada Echanojáuregui A; Moreno Planas JM; Rubio González E; Portero Azorin F; López Monclús J; Revilla Negro J; Lucena de la Poza JL; Sánchez Turrión V; Barrios Peinado C; Cuervas-Mons Martínez V Transplant Proc; 2005 Apr; 37(3):1507-8. PubMed ID: 15866657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]